Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04565639 · ClinicalTrials.gov registry record · NA

Hand Assistive Rehabilitation Orthotic Device Effectiveness Study

A NA study, sponsored by Liberating Technologies.

Completed
Registry status
NA
Development phase
3
Enrollment target

NCT04565639: Completed NA study, sponsored by Liberating Technologies.

NCT04565639 is a NA study that has completed, run by Liberating Technologies. The registered enrollment target is 3 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04565639, a NA study, has completed, sponsored by Liberating Technologies.

COMPLETED
Registry status
NA
Development phase
3 participants
Enrollment target

Study Summary

The primary objective of this study is to evaluate pinch strength improvements and improvements in coordination and functional ability. Pinch strength measurements are made on subjects both with and without the device to evaluate the potential improvements. Also, coordination and functional testing is performed both with and without the device to compare performance under both conditions and evaluate potential improvement.

Primary Outcome

The sustained grip available for achieving activities of daily living that require a sustained grip

Interventions

  • DEVICE Powered Hand Orthosis

Trial Details

FieldValue
Enrollment Target 3 participants
Start Date 2019-08-14
Est. Completion 2019-11-07
Phase NA
Liberating Technologies

13 total trials

What the finished NCT04565639 record still lists

NCT04565639 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).

The record links to 0 conditions, and to 1 intervention - of which Powered Hand Orthosis is the first listed.

NCT04565639 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04565639 about?

NCT04565639 is a clinical study titled "Hand Assistive Rehabilitation Orthotic Device Effectiveness Study". The primary objective of this study is to evaluate pinch strength improvements and improvements in coordination and functional ability. Pinch strength measurements are made on subjects both with and without the device to evaluate the potential improvements. Also, coordination and functional testing ...

What is the current status of trial NCT04565639?

This trial is currently completed. It is a NA study. The enrollment target is 3 participants. The study started on 2019-08-14. Estimated completion is 2019-11-07.

What interventions are being tested in trial NCT04565639?

The interventions under investigation include: Powered Hand Orthosis (DEVICE).

Who is sponsoring clinical trial NCT04565639?

This trial is sponsored by Liberating Technologies, which has 13 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04565639's enrollment target sits among peer trials

3 1996th of 2000 higher than 4 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04565639, the US trial registry maintained by the National Library of Medicine. NCT04565639 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.